Atopaxar and its effects on markers of platelet activation and inflammation: results from the LANCELOT CAD program.
O'Donoghue ML, Bhatt DL, Flather MD, Goto S, Angiolillo DJ, Goodman SG, Zeymer U, Aylward PE, Montalescot G, Ziecina R, Kobayashi H, Ren F, Wiviott SD.
O'Donoghue ML, et al. Among authors: ren f.
J Thromb Thrombolysis. 2012 Jul;34(1):36-43. doi: 10.1007/s11239-012-0750-6.
J Thromb Thrombolysis. 2012.
PMID: 22653705
Clinical Trial.